IBDEI0B3 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4994,0)
 ;;=96361^^26^317^2^^^^1
 ;;^UTILITY(U,$J,358.3,4994,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4994,1,2,0)
 ;;=2^96361
 ;;^UTILITY(U,$J,358.3,4994,1,3,0)
 ;;=3^IV INF,HYDRATION,EA ADDL HR
 ;;^UTILITY(U,$J,358.3,4995,0)
 ;;=96365^^26^317^3^^^^1
 ;;^UTILITY(U,$J,358.3,4995,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4995,1,2,0)
 ;;=2^96365
 ;;^UTILITY(U,$J,358.3,4995,1,3,0)
 ;;=3^IV INF,THER/PROPH,UP TO 1 HR
 ;;^UTILITY(U,$J,358.3,4996,0)
 ;;=96366^^26^317^4^^^^1
 ;;^UTILITY(U,$J,358.3,4996,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4996,1,2,0)
 ;;=2^96366
 ;;^UTILITY(U,$J,358.3,4996,1,3,0)
 ;;=3^IV INF,THER/PROPH,EA ADDL HR
 ;;^UTILITY(U,$J,358.3,4997,0)
 ;;=96374^^26^317^5^^^^1
 ;;^UTILITY(U,$J,358.3,4997,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4997,1,2,0)
 ;;=2^96374
 ;;^UTILITY(U,$J,358.3,4997,1,3,0)
 ;;=3^IV PUSH,SINGLE/INIT SUBS/DRUG
 ;;^UTILITY(U,$J,358.3,4998,0)
 ;;=96375^^26^317^6^^^^1
 ;;^UTILITY(U,$J,358.3,4998,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4998,1,2,0)
 ;;=2^96375
 ;;^UTILITY(U,$J,358.3,4998,1,3,0)
 ;;=3^IV PUSH,EA SUBSQUENT PUSH
 ;;^UTILITY(U,$J,358.3,4999,0)
 ;;=S9445^^26^318^1^^^^1
 ;;^UTILITY(U,$J,358.3,4999,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,4999,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,4999,1,3,0)
 ;;=3^PT EDUCATION INDIVID NON-MD
 ;;^UTILITY(U,$J,358.3,5000,0)
 ;;=99071^^26^318^2^^^^1
 ;;^UTILITY(U,$J,358.3,5000,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5000,1,2,0)
 ;;=2^99071
 ;;^UTILITY(U,$J,358.3,5000,1,3,0)
 ;;=3^PATIENT EDUCATION MATERIALS
 ;;^UTILITY(U,$J,358.3,5001,0)
 ;;=0505F^^26^319^1^^^^1
 ;;^UTILITY(U,$J,358.3,5001,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5001,1,2,0)
 ;;=2^0505F
 ;;^UTILITY(U,$J,358.3,5001,1,3,0)
 ;;=3^HEMODIALYSIS PLAN DOCD
 ;;^UTILITY(U,$J,358.3,5002,0)
 ;;=B4164^^26^320^7^^^^1
 ;;^UTILITY(U,$J,358.3,5002,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5002,1,2,0)
 ;;=2^B4164
 ;;^UTILITY(U,$J,358.3,5002,1,3,0)
 ;;=3^ENTERAL FORMULA, CAT IV
 ;;^UTILITY(U,$J,358.3,5003,0)
 ;;=A4730^^26^320^8^^^^1
 ;;^UTILITY(U,$J,358.3,5003,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5003,1,2,0)
 ;;=2^A4730
 ;;^UTILITY(U,$J,358.3,5003,1,3,0)
 ;;=3^FISTULA CANNULATION SET, EA
 ;;^UTILITY(U,$J,358.3,5004,0)
 ;;=B5000^^26^320^10^^^^1
 ;;^UTILITY(U,$J,358.3,5004,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5004,1,2,0)
 ;;=2^B5000
 ;;^UTILITY(U,$J,358.3,5004,1,3,0)
 ;;=3^PARENT NUT SOL,ANY STRTH,RENAL
 ;;^UTILITY(U,$J,358.3,5005,0)
 ;;=A4714^^26^320^12^^^^1
 ;;^UTILITY(U,$J,358.3,5005,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5005,1,2,0)
 ;;=2^A4714
 ;;^UTILITY(U,$J,358.3,5005,1,3,0)
 ;;=3^TREATED WATER PER GALLON
 ;;^UTILITY(U,$J,358.3,5006,0)
 ;;=C1752^^26^320^5^^^^1
 ;;^UTILITY(U,$J,358.3,5006,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5006,1,2,0)
 ;;=2^C1752
 ;;^UTILITY(U,$J,358.3,5006,1,3,0)
 ;;=3^CATH,HEMODIALYSIS,SHORT-TERM
 ;;^UTILITY(U,$J,358.3,5007,0)
 ;;=C1750^^26^320^4^^^^1
 ;;^UTILITY(U,$J,358.3,5007,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5007,1,2,0)
 ;;=2^C1750
 ;;^UTILITY(U,$J,358.3,5007,1,3,0)
 ;;=3^CATH, HEMODIALYSIS,LONG-TERM
 ;;^UTILITY(U,$J,358.3,5008,0)
 ;;=85302^^26^320^3^^^^1
 ;;^UTILITY(U,$J,358.3,5008,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5008,1,2,0)
 ;;=2^85302
 ;;^UTILITY(U,$J,358.3,5008,1,3,0)
 ;;=3^BLOOD CLOT INHIBITOR ANTIGEN
 ;;^UTILITY(U,$J,358.3,5009,0)
 ;;=99070^^26^320^2^^^^1
 ;;^UTILITY(U,$J,358.3,5009,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5009,1,2,0)
 ;;=2^99070
 ;;^UTILITY(U,$J,358.3,5009,1,3,0)
 ;;=3^AV FISTULA KIT
 ;;^UTILITY(U,$J,358.3,5010,0)
 ;;=A9900^^26^320^11^^^^1
